Skip to content

13F-HR filed by Commodore Capital LP

Commodore Capital LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 35 holding rows worth $1,465,008,171.

Accession
0001880562-24-000002
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 35 entries on the cover page, a total value of $1,465,008,171 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,465,008,171 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MERUS N VN5749R100COM3,200,000$189,344,000dollars as filed
NUVALENT INC COM670703107Stock1,487,756$112,861,170dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock2,754,266$107,388,831dollars as filed
VAXCYTE INC COM92243G108Stock1,305,000$98,540,550dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock3,973,245$92,854,736dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK2,475,000$89,545,500dollars as filed
COGENT BIOSCIENCES INC19240Q201COM9,738,000$82,091,340dollars as filed
SOLENO THERAPEUTICS INC834203309COM1,425,000$58,140,000dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW1,425,000$52,739,250dollars as filed
MIND MEDICINE MINDMED INC60255C885COM NEW7,145,888$51,521,852dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM1,225,000$50,298,500dollars as filed
ARVINAS INC04335A105COM1,884,361$50,161,690dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW1,988,084$46,739,855dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK4,657,345$46,433,730dollars as filed
PHARVARIS NVN69605108COMMON STOCK1,810,175$34,031,290dollars as filed
ALKERMES PLCG01767105SHS1,375,000$33,137,500dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM2,528,032$32,889,696dollars as filed
KURA ONCOLOGY INC COM50127T109Stock1,593,350$32,807,077dollars as filed
NKARTA INC65487U108COMMON STOCK4,151,034$24,532,611dollars as filed
CELCUITY INC15102K100COM1,464,105$23,982,040dollars as filed
THIRD HARMONIC BIO INC88427A107COM1,545,426$20,090,538dollars as filed
IMMUNOVANT INC45258J102COM750,990$19,826,136dollars as filed
ABIVAX SA-00370M103SPONSORED ADS1,284,110$16,975,934dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM825,000$16,937,250dollars as filed
C4 THERAPEUTICS INC12529R107COM STK3,410,384$15,755,974dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM2,000,000$14,140,000dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock290,000$11,411,500dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK1,100,000$8,228,000dollars as filed
PERCEPTIVE CAPITAL SOLUTIONSG70077105CL A ORD SHS750,000$7,545,000dollars as filed
NEUROGENE INC64135M105COMMON STOCK200,000$7,278,000dollars as filed
VISTAGEN THERAPEUTICS INC92840H400COM1,575,000$5,481,000dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS500,000$5,110,000dollars as filed
AUTOLUS THERAPEUTICS PLC SPON05280R100COM1,178,723$4,101,956dollars as filed
ORUKA THERAPEUTICS INC COM00211Y506Stock414,325$1,586,865dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK40,000$498,800dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001880562-24-000002this filing2024-08-14acceptance time not in the bulk data set